Tau45-230 association with the cytoskeleton and membrane-bound organelles

Functional implications in neurodegeneration

Sana Afreen, D. Nicole Riherd Methner, Adriana B Ferreira*

*Corresponding author for this work

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

The dysregulation of posttranslational modifications of the microtubule-associated protein (MAP) tau plays a key role in Alzheimer's disease (AD) and related disorders. Thus, we have previously shown that beta amyloid (Aβ)-induced neurotoxicity was mediated, at least in part, by tau cleavage into the tau45-230 fragment. However, the mechanisms underlying the toxicity of tau45-230 remain unknown. To get insights into such mechanisms, we first determined the subcellular localization of this tau fragment in hippocampal neurons. Tau45-230 was easily detectable in cell bodies and processes extended by these neurons. In addition, cell extraction experiments performed using Triton X-100 and saponin showed that a pool of tau45-230 was associated with the cytoskeleton and the cytoskeleton plus membrane-bound organelles, respectively, in cultured hippocampal neurons. Furthermore, they suggested that these associations were independent of the presence of full-length tau. We also assessed whether this tau fragment could alter axonal transport. Our results indicated that tau45-230 significantly reduced the number of organelles transported along hippocampal axons. This altered axonal transport did not correlate with changes in the total number of organelles present in these cells or in motor protein levels. Together these results suggested that tau45-230 could exert its toxic effects by partially blocking axonal transport along microtubules thus contributing to the early pathology of AD.

Original languageEnglish (US)
Pages (from-to)104-117
Number of pages14
JournalNeuroscience
Volume362
DOIs
StatePublished - Oct 24 2017

Fingerprint

Axonal Transport
Cytoskeleton
Organelles
Neurons
Membranes
Alzheimer Disease
Microtubule-Associated Proteins
Poisons
Saponins
Octoxynol
Post Translational Protein Processing
Amyloid
Microtubules
Axons
Pathology
Proteins

Keywords

  • axonal transport
  • cytoskeleton
  • degeneration
  • lysosomes
  • mitochondria

ASJC Scopus subject areas

  • Neuroscience(all)

Cite this

@article{5dad16851b3e4aee91f2dc28d86adfa9,
title = "Tau45-230 association with the cytoskeleton and membrane-bound organelles: Functional implications in neurodegeneration",
abstract = "The dysregulation of posttranslational modifications of the microtubule-associated protein (MAP) tau plays a key role in Alzheimer's disease (AD) and related disorders. Thus, we have previously shown that beta amyloid (Aβ)-induced neurotoxicity was mediated, at least in part, by tau cleavage into the tau45-230 fragment. However, the mechanisms underlying the toxicity of tau45-230 remain unknown. To get insights into such mechanisms, we first determined the subcellular localization of this tau fragment in hippocampal neurons. Tau45-230 was easily detectable in cell bodies and processes extended by these neurons. In addition, cell extraction experiments performed using Triton X-100 and saponin showed that a pool of tau45-230 was associated with the cytoskeleton and the cytoskeleton plus membrane-bound organelles, respectively, in cultured hippocampal neurons. Furthermore, they suggested that these associations were independent of the presence of full-length tau. We also assessed whether this tau fragment could alter axonal transport. Our results indicated that tau45-230 significantly reduced the number of organelles transported along hippocampal axons. This altered axonal transport did not correlate with changes in the total number of organelles present in these cells or in motor protein levels. Together these results suggested that tau45-230 could exert its toxic effects by partially blocking axonal transport along microtubules thus contributing to the early pathology of AD.",
keywords = "axonal transport, cytoskeleton, degeneration, lysosomes, mitochondria",
author = "Sana Afreen and {Riherd Methner}, {D. Nicole} and Ferreira, {Adriana B}",
year = "2017",
month = "10",
day = "24",
doi = "10.1016/j.neuroscience.2017.08.026",
language = "English (US)",
volume = "362",
pages = "104--117",
journal = "Neuroscience",
issn = "0306-4522",
publisher = "Elsevier Limited",

}

Tau45-230 association with the cytoskeleton and membrane-bound organelles : Functional implications in neurodegeneration. / Afreen, Sana; Riherd Methner, D. Nicole; Ferreira, Adriana B.

In: Neuroscience, Vol. 362, 24.10.2017, p. 104-117.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Tau45-230 association with the cytoskeleton and membrane-bound organelles

T2 - Functional implications in neurodegeneration

AU - Afreen, Sana

AU - Riherd Methner, D. Nicole

AU - Ferreira, Adriana B

PY - 2017/10/24

Y1 - 2017/10/24

N2 - The dysregulation of posttranslational modifications of the microtubule-associated protein (MAP) tau plays a key role in Alzheimer's disease (AD) and related disorders. Thus, we have previously shown that beta amyloid (Aβ)-induced neurotoxicity was mediated, at least in part, by tau cleavage into the tau45-230 fragment. However, the mechanisms underlying the toxicity of tau45-230 remain unknown. To get insights into such mechanisms, we first determined the subcellular localization of this tau fragment in hippocampal neurons. Tau45-230 was easily detectable in cell bodies and processes extended by these neurons. In addition, cell extraction experiments performed using Triton X-100 and saponin showed that a pool of tau45-230 was associated with the cytoskeleton and the cytoskeleton plus membrane-bound organelles, respectively, in cultured hippocampal neurons. Furthermore, they suggested that these associations were independent of the presence of full-length tau. We also assessed whether this tau fragment could alter axonal transport. Our results indicated that tau45-230 significantly reduced the number of organelles transported along hippocampal axons. This altered axonal transport did not correlate with changes in the total number of organelles present in these cells or in motor protein levels. Together these results suggested that tau45-230 could exert its toxic effects by partially blocking axonal transport along microtubules thus contributing to the early pathology of AD.

AB - The dysregulation of posttranslational modifications of the microtubule-associated protein (MAP) tau plays a key role in Alzheimer's disease (AD) and related disorders. Thus, we have previously shown that beta amyloid (Aβ)-induced neurotoxicity was mediated, at least in part, by tau cleavage into the tau45-230 fragment. However, the mechanisms underlying the toxicity of tau45-230 remain unknown. To get insights into such mechanisms, we first determined the subcellular localization of this tau fragment in hippocampal neurons. Tau45-230 was easily detectable in cell bodies and processes extended by these neurons. In addition, cell extraction experiments performed using Triton X-100 and saponin showed that a pool of tau45-230 was associated with the cytoskeleton and the cytoskeleton plus membrane-bound organelles, respectively, in cultured hippocampal neurons. Furthermore, they suggested that these associations were independent of the presence of full-length tau. We also assessed whether this tau fragment could alter axonal transport. Our results indicated that tau45-230 significantly reduced the number of organelles transported along hippocampal axons. This altered axonal transport did not correlate with changes in the total number of organelles present in these cells or in motor protein levels. Together these results suggested that tau45-230 could exert its toxic effects by partially blocking axonal transport along microtubules thus contributing to the early pathology of AD.

KW - axonal transport

KW - cytoskeleton

KW - degeneration

KW - lysosomes

KW - mitochondria

UR - http://www.scopus.com/inward/record.url?scp=85028914147&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85028914147&partnerID=8YFLogxK

U2 - 10.1016/j.neuroscience.2017.08.026

DO - 10.1016/j.neuroscience.2017.08.026

M3 - Article

VL - 362

SP - 104

EP - 117

JO - Neuroscience

JF - Neuroscience

SN - 0306-4522

ER -